The safety and efficacy of topiramate in male patients with abdominal obesity: a 6-month double-blind, randomized, placebo-controlled study with a 6-month open-label extension.

Next Previous
Trial Profile

The safety and efficacy of topiramate in male patients with abdominal obesity: a 6-month double-blind, randomized, placebo-controlled study with a 6-month open-label extension.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2009

At a glance

  • Drugs Topiramate (Primary)
  • Indications Obesity
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 04 Apr 2007 Status change
    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top